<p>Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers</p>

Abstract

This is the first study to elucidate the clinical outcomes of osteosarcoma in relation to PD-L1, PRF, GZMB, and IFNγ expression. This study provides valuable information regarding the clinical indication and prediction of effect for anti-PD-1 antibody in osteosarcoma.